Exit / M&A
Identifai Genetics raises $6.96M in ASX debut for prenatal screening platform
Identifai Genetics has joined the ASX after raising about US$6.47 million in its IPO, with proceeds going toward its non-invasive prenatal screening platform Windrose; Aesir Corporate managed the offer.